Ubivac (Ubivac)

Oncology Corporate Profile

HQ Location

4805 NE Glisan
2N56 North Pavilion
Portland, OR 97213

Company Description

UbiVac is a company that offers a pipeline of groundbreaking immunotherapies in preclinical and clinical stage trials. Since 2005 the company has been engaged in the research, development and testing of therapeutic immunotherapy strategies to combat cancer and infectious diseases.

Website: http://ubivac.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
DPV-001toll-like receptorNon Small Cell Lung Cancer (NSCLC)II
DPV-002toll-like receptorBreast cancerPreclinical
DPV-001 (+ anti-PD-1)toll-like receptorNon Small Cell Lung Cancer (NSCLC)Preclinical
DPV-001toll-like receptorProstate cancerPreclinical
DPV-004toll-like receptorVarious cancer typesPreclinical
DPV-003HPVtoll-like receptorVarious cancer typesPreclinical

View additional information on product candidates here »

Source: http://ubivac.com

Recent News Headlines

There are no news items to display